TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Edwards Lifesciences Nordic AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
46,828
|
44,297
|
43,963 |
Financial expenses |
179
|
94
|
58 |
Earnings before taxes |
1,852
|
2,179
|
1,494 |
EBITDA |
2,020
|
2,280
|
1,578 |
Total assets |
14,759
|
16,023
|
15,158 |
Current assets |
14,693
|
15,983
|
15,092 |
Current liabilities |
6,612
|
9,176
|
9,402 |
Equity capital |
7,844
|
6,537
|
5,056 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
36
|
31
|
34 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
53.1%
|
40.8%
|
33.4% |
Turnover per employee |
1,301
|
1,429
|
1,293 |
Profit as a percentage of turnover |
4.0%
|
4.9%
|
3.4% |
Return on assets (ROA) |
13.8%
|
14.2%
|
10.2% |
Current ratio |
222.2%
|
174.2%
|
160.5% |
Return on equity (ROE) |
23.6%
|
33.3%
|
29.5% |
Change turnover |
2,403
|
3,895
|
1,871 |
Change turnover % |
5%
|
10%
|
4% |
Chg. No. of employees |
5
|
-3
|
0 |
Chg. No. of employees % |
16%
|
-9%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.